Indukaka Ipcowala College of Pharmacy, Beyond GIDC Phase IV, Vithal Udyognagar, New Vallabh Vidyanagar, Anand, Gujarat, India.
Drug Dev Ind Pharm. 2009 Oct;35(10):1155-66. doi: 10.1080/03639040902810422.
Microencapsulation of the anti-inflammatory drug aceclofenac (ACE) was investigated as a means of controlling drug release and minimizing or eliminating local side effects.
Microspheres were prepared by a spray-drying technique using solutions of ACE and three polymers, namely, carbopol, chitosan, and polycarbophil, in different weight ratios.
The spray-dried mucoadhesive microspheres were characterized in terms of shape (scanning electron microscope), size (6.60-8.40 mum), production yield (34.10-55.62%), and encapsulation efficiency (58.14-90.57%). In vitro release studies were performed in phosphate buffer (pH 6.8) up to 10 hours. The spray-drying process of solutions of ACE with polymeric blends can give prolonged drug release. The in vitro release data were well fit into Higuchi and Korsmeyer-Peppas model and followed Fickian diffusion mechanism. In vivo data showed that the administration of ACE in polymeric microspheres prevented the gastric side effects.
The formulations here described can be proposed for the oral administration of nonsteroidal anti-inflammatory drugs with minimal side effects on gastric mucosa.
将抗炎药物醋氯芬酸(ACE)包封微球,旨在控制药物释放并最小化或消除局部副作用。
采用喷雾干燥技术,使用 ACE 和三种聚合物(卡波姆、壳聚糖和聚卡波非)的溶液,以不同的重量比制备微球。
喷雾干燥的黏附性微球在形状(扫描电子显微镜)、大小(6.60-8.40 微米)、产率(34.10-55.62%)和包封效率(58.14-90.57%)方面进行了表征。在 pH6.8 的磷酸盐缓冲液中进行了长达 10 小时的体外释放研究。含有聚合物混合物的 ACE 溶液的喷雾干燥过程可以延长药物的释放。体外释放数据符合 Higuchi 和 Korsmeyer-Peppas 模型,并遵循菲克扩散机制。体内数据表明,将 ACE 制成聚合物微球可防止胃肠道副作用。
所描述的制剂可用于口服非甾体抗炎药物,对胃黏膜的副作用最小。